Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (S)-(-)-O-Demethylbuchenavianine | C17H20N8O4 | 91147-18-1 | Details |
| BCN-endo-PEG7-NH2 | C27H48N2O9 | 2143968-34-5 | Details |
| JNJ-18038683 free base | C20H20ClN3 | 851373-91-6 | Details |
| ABHD antagonist 1 | C19H20BrN3O3S | 3034510-10-3 | Details |
| PI3K-IN-49 | C26H31FN4O3 | 2922415-69-6 | Details |
| DDD00057570 | C17H17N5O | 338965-07-4 | Details |
| Me-Tet-PEG4-NH2 | C21H32N6O5 | 2055646-21-2 | Details |
| Me-Tet-PEG4-Maleimide | C28H37N7O8 | 1715913-76-0 | Details |
| CBP/p300 ligand 3 | C22H24F2N6O | 1936425-34-1 | Details |
| Thyroid hormone receptor beta agonist-1 | C35H45O9P | 2140902-80-1 | Details |
| SQA1 | C22H26N4O5 | 1255915-27-5 | Details |
| Eg5-IN-2 | C31H38F3N5O3 | 1629735-05-2 | Details |
| JH530 | C22H24BrN7O2S | 2928616-74-2 | Details |
| MC-Ala-Ala-Asn-PAB-PNP | C34H39N7O12 | 1638970-45-2 | Details |
| (R)-(+)-O-Demethylbuchenavianine | C21H21NO4 | 1364123-68-1 | Details |
| IM-2 | C29H35N7O10S | 2813269-89-3 | Details |
| PI3K-IN-50 | C24H25F4N5O3 | 3023536-43-5 | Details |
| N-Decanoyl cyclopentylamide | C15H29NO | 540796-75-6 | Details |
| Benzyl 2-cyclopropyl-2-hydroxyacetate | C12H14O3 | 182747-31-5 | Details |
| Butyrate-Vitamin D3 | C31H50O2 | 31316-20-8 | Details |
| Me-Tet-PEG9-COOH | C32H51N5O12 | 2143964-70-7 | Details |
| SCO-PEG3-Maleimide | C24H35N3O8 | 2141976-35-2 | Details |
| Tirilazad mesylate hydrate | CH5O4S- | 111793-42-1 | Details |
| AdipoR agonist 1 | C26H35N3O3 | 949745-75-9 | Details |
| (Z,Z)-3,13-Octadecadien-1-ol | C18H34O | 66410-24-0 | Details |
| BT317 | C17H12ClNO4 | 38485-94-8 | Details |
| CDK4/6-IN-20 | C23H24FN5O2 | 3033950-84-1 | Details |
| IRE1a-IN-2 | C19H19NO6S | 3033375-24-2 | Details |
| PI3Kα-IN-19 | C28H28N6O3 | 885692-56-8 | Details |
| PT-88 | C30H31N7O5 | 2803307-04-0 | Details |
| TLR7 agonist 17 | C25H37N7O3 | 2410517-32-5 | Details |
| BCN-exo-PEG3-maleimide | C26H37N3O8 | 2919127-00-5 | Details |
| HSD17B13-IN-41 | C17H14O2S | 1122660-25-6 | Details |
| P-gp inhibitor 17 | C36H49N3O3 | 2556388-58-8 | Details |
| Exatecan-amide-bicyclo[1.1.1]pentan-1-ol | C30H28FN3O6 | 2866299-06-9 | Details |
| β-Glu-PNP | C33H38N2O17 | 3025520-67-3 | Details |
| JJC8-088 | C28H32F2N2O2S | 1627576-82-2 | Details |
| HSD17B13-IN-39 | C15H11NO2 | 2730022-55-4 | Details |
| Tiopropamine | C24H27NS | 39516-21-7 | Details |
| Ethacridine | C15H15N3O | 442-16-0 | Details |
| Tinazoline | C11H11N3S | 62882-99-9 | Details |
| Bitipazone | C20H38N8S2 | 13456-08-1 | Details |
| cBu-Cit-OH | C28H38N6O7 | 1799663-03-8 | Details |
| MDI-2268 | C10H10F3N3O3 | 1609176-50-2 | Details |
| BCN-endo-PEG2-maleimide | C24H33N3O7 | 2675364-08-4 | Details |
| SCO-PEG3-NH2 | C17H30N2O5 | 2141976-29-4 | Details |
| Amiselimod | C19H30F3NO3 | 942399-20-4 | Details |
| PG-11047 tetrahydrochloride | C14H33ClN4 | 206991-64-2 | Details |
| FPT | C18H20FN | 2048491-06-9 | Details |
| STAT3-IN-25 | C36H29F6N7O4 | 2591440-75-2 | Details |
| MC-Val-D-Cit-PAB-PNP | C35H43N7O11 | 1350456-66-4 | Details |
| (S)-Elobixibat | C36H45N3O7S2 | 439087-68-0 | Details |
| Peraquinsin | C23H28N4O4 | 35265-50-0 | Details |
| Opabactin | C22H26N2O3 | 2407423-32-7 | Details |
| H-L-Lys(Norbornene-methoxycarbonyl)-OH hydrochloride | C15H24N2O4.ClH | 2560614-20-0 | Details |
| NMS-P528 | C27H28ClN3O3S | 1466546-45-1 | Details |
| CSF1R-IN-24 | C26H24N6O3 | 3024322-57-1 | Details |
| Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol | C31H30FN3O6 | 2891774-71-1 | Details |
| Firefly luciferase-IN-3 | C24H21F3N4O4 | 898155-17-4 | Details |
| TEAD-IN-13 | C23H22F3N3O4 | 3034813-74-3 | Details |
| TLR8 agonist 9 | C38H43N7O8 | 3034750-61-0 | Details |
| Zavolosotine | C20H18F5N5O | 2604416-66-0 | Details |
| HDAC-IN-73 | C22H24Br2N4O6Se2 | 2323571-16-8 | Details |
| CYP11B2-IN-2 | C16H13FN2O2 | 2241573-22-6 | Details |
| Ticarcillin monosodium | C15H14N2Na2O6S2 | 74682-62-5 | Details |
| Fmoc-(D-Phe)-OSu | C28H24N2O6 | 182410-73-7 | Details |
| MP-Ala-Ala-PAB | C20H24N4O6 | 1949793-47-8 | Details |
| Exatecan analogue 1 | C23H20FN3O4 | 2671770-58-2 | Details |
| Bisfentidine | C14H18N4 | 96153-56-9 | Details |
| Fmoc-Gly-Gly-allyl propionate | C25H26N2O7 | 2766214-15-5 | Details |
| Microtubule inhibitor 8 | C21H15N3O2S | 2310293-81-1 | Details |
| EF-4-177 | C18H13F5N3O2S.H | 2891574-93-7 | Details |
| MDM2-p53-IN-18 | C19H16Cl2FN3O4 | 1818291-95-0 | Details |
| Me-Tet-PEG2-NHS | C23H28N6O7 | 2740357-12-2 | Details |
| Toripristone | C31H39NO2 | 91935-26-1 | Details |
| P-gp inhibitor 14 | 2892571-47-8 | Details |
| 7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) | C25H24FN3O7 | 2873460-17-2 | Details |
| JA310 | C17H19N7O | 3022928-90-8 | Details |
| EGFR T790M/L858R-IN-8 | C16H11BrN2O3 | 333419-97-9 | Details |
| UMM-766 | C12H15FN4O4 | 443643-17-2 | Details |
| Me-Tet-PEG3-NHBoc | C24H36N6O6 | 2141976-32-9 | Details |
| Mycobacterium Tuberculosis-IN-2 | 2284580-65-8 | Details |
| NIP-22c | C32H39N5O6 | 2309384-85-6 | Details |
| PI3Kα-IN-20 | C22H24N4O4 | 228999-57-3 | Details |
| Tup hydrochloride | C12H18ClNO3 | 1200041-11-7 | Details |
| Timolol hemimaleate | C30H52N8O10S2 | 33305-95-2 | Details |
| 1,6-Bis(mesyloxy)hexane | C8H18O6S2 | 4239-24-1 | Details |
| Zaltidine dihydrochloride | C8H12Cl2N6S | 90274-23-0 | Details |
| THR-β modulator-2 | C17H14Cl2N6O4 | 2542029-56-9 | Details |
| (1S,9R)-Exatecan mesylate | C24H22FN3O4.CH4O3S | 2938875-54-6 | Details |
| HBV/HDV-IN-2 | C38H44ClN7O5 | 3034161-76-4 | Details |
| NH2-PEG4-GGFG-CH2-O-CH2-Cbz | C36H52N6O12 | 2914227-55-5 | Details |
| PCSK9-IN-23 | C22H18F6N2O | 2115700-96-2 | Details |
| P-gp inhibitor 22 | C20H13ClN2O2 | 1226674-74-3 | Details |
| Zemprocitinib | C16H19N5O2S | 2417414-44-7 | Details |
| Amiclenomycin | 53696-70-1 | Details |
| Rocuronium | C32H53N2O4+ | 143558-00-3 | Details |
| Laserine oxide | C21H26O8 | 82433-10-1 | Details |
| Iobitridol | C20H28I3N3O9 | 136949-58-1 | Details |
| Mideplanin | C93H109Cl2N11O32 | 122173-74-4 | Details |
| Product Total： Product Page： | ||||
| 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 | ||||